EGC Profiled in WRAL TechWire

Article highlights EGC’s success in supporting the NIH’s Applicant Assistance Program and winning the SBA’s Growth Accelerator Fund Competition award.

EGC & the NIH Significantly Expand Participation in SBIR Grants

Nature Biotechnology article showcases the first programmatic intervention proven to broaden representation among SBIR grant awardees in four decades.

EGC and Brooks Pierce co-hosts new webinar series

Exclusive opportunity for EGC clients: Please join us for a four-part grant accounting and legal compliance webinar series that runs between July and October 2024.

June 17: Dr. Garland Moderated Panel at TechConnect

EGC is attending the SBIR/STTR Spring Innovation Conference (June 17-18, 2024, in Washington, DC)!

EGC Spring Webinar Series

EGC presents a 3-part webinar series as our Scientific Grant Writing Experts dive into what it takes to develop competitive proposals to secure CDMRP, ARPA-H, and NIH SBIR/STTR funding!

EGC Wins 2024 Growth Accelerator Fund Competition

Eva Garland Consulting, LLC (EGC) has received a 2024 Growth Accelerator Fund Competition (GAFC) award from the Small Business Administration (SBA), in recognition of the firm’s impactful contributions toward increasing equitable access to resources for entrepreneurs from underrepresented groups.

Senior Grants Expert Dr. Tiger Xie Featured at NCATS Webinar

Dr. Xiaohu (Tiger) Xie, is a featured speaker at the National Center for Advancing Translational Science (NCATS) and Georgia Clinical & Translational Science Alliance (CTSA’s) Small Business Funding Webinar.

Dr. Garland Participates in Women+ in Climate Tech Global Network Panel Discussion

Dr. Eva Garland joins Justina W. Gallegos, Deputy Director, White House Office of Science and Technology Policy; Maya Goodwin, Senior Advisor, Workforce and Economic Opportunity Policy, Department of Energy

EGC Sponsors RESI at JPM Conference in San Francisco

EGC is pleased to sponsor the Redefining Early Stage Investments (RESI) Conference at the JP Morgan Conference in San Francisco on January 9, 2024.

EGC’s Dr. Heaney Presents at BioVenture Nexus in LA

The EGC Team attends BioVenture Nexus located at the JW Marriott-The Ritz Carlton Los Angeles, CA. BioVenture Nexus is the premier event for innovation and networking in the Synthetic Biology, Biotech Industry, Life Science, Food Tech, and AI in Biology.

EGC Receives Six-Time Inc. 5000 Recognition

Eva Garland Consulting, LLC (EGC) is excited once again to be named as one of the fastest growing privately owned companies in the United States by capturing a spot on the Inc. 5000 list for the sixth consecutive year.

EGC’s Leadership of NIH AAP Enters 5th Year

Eva Garland Consulting (EGC) is thrilled to extend our partnership with the National Institutes of Health (NIH) to support small businesses in developing SBIR/STTR proposals through the NIH Applicant Assistance Program (AAP).

EGC Presents at a NCATS Workshop on Non-Dilutive Funding

Dr. Xiaohu (Tiger) Xie, a Scientific Grants Expert from Eva Garland Consulting, presents a talk titled “Application Tips & Resources to Help Secure SBIR & STTR Funding”, sponsored by the NIH's National Center for Advancing Translation Science (NCATS).

Dr. Garland Moderates Panel at National SBIR Conference

EGC is pleased to announce that our CEO, Dr. Eva Garland, is moderating a panel titled "Executing My Award" at the SBIR/STTR Spring Innovation Conference.

EGC Releases New SBIR Book

Eva Garland Consulting (EGC) is excited to announce the publication of the 4th edition of our Amazon best-selling book on the NIH SBIR/STTR program.